Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0001127602-22-013206

EVP, Chief Financial Officer acquired 5,902 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
DArecca James EVP, Chief Financial Officer 2022-05-02 Grant or award +5,902 5,902 D
Derivatives
DArecca James EVP, Chief Financial Officer 2022-05-02 Grant or award · Non-qualified Stock Option (Right to Buy) +13,828 13,828 D
Loading xslF345X03/form4.xml…